AngioScore Announces 510 (k) distance from the market AngioSculpt scoring balloon catheter for renal information
Article reviews: 0 posts AngioScore, Inc., a developer of innovative angioplasty catheters for use in the treatment of cardiovascular diseases, announced that the company 510(k) distance from the US and Drug Administration (FDA) to its AngioSculpt ® PTA scoring balloon catheter market has received for dilation of lesions in renal arteries. AngioScore had clearance 510(k) previously AngioSculpt device of dilation of lesions in the iliaca, Femoral, Illio femoralis, poplitea and infrared of poplitea arteries and for the treatment of obstructive lesions native or synthetic arterio dialysis fistulae the market erhalten.Diese new 510(k)-Abstand adds renal arteries specified use for statement. According to Gary Gershony, m.d, AngioScore of the Chief Medical Officer, AngioSculpt in renal artery of stenotic disease treatment can often medically refractory hypertension or a serious deterioration in the kidney function assigned is especially be useful: "because of the frequency of major cal...